SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-095681
Filing Date
2023-08-28
Accepted
2023-08-28 08:38:10
Documents
4
Effectiveness Date
2023-08-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2324400d1_s8.htm S-8 57609
2 EXHIBIT 5.1 tm2324400d1_ex5-1.htm EX-5.1 7050
3 EXHIBIT 23.1 tm2324400d1_ex23-1.htm EX-23.1 2144
4 EX-FILING FEES tm2324400d1_ex-filingfees.htm EX-FILING FEES 16285
  Complete submission text file 0001104659-23-095681.txt   84241
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274234 | Film No.: 231210420
SIC: 2836 Biological Products, (No Diagnostic Substances)